Cadonilimab (AK104)

Cadonilimab · Akeso, Inc.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Cadonilimab (AK104), covering 2024-05-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Follow-up Study of Subjects Enrolled in Clinical Trials of Cadonilimab (AK104)